Verition Fund Management LLC Wave Life Sciences Ltd. Transaction History
Verition Fund Management LLC
- $20.3 Billion
- Q2 2025
A detailed history of Verition Fund Management LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Verition Fund Management LLC holds 52,728 shares of WVE stock, worth $445,551. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,728
Previous 154,757
65.93%
Holding current value
$445,551
Previous $1.25 Million
72.64%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding WVE
# of Institutions
191Shares Held
132MCall Options Held
551KPut Options Held
47.1K-
Ra Capital Management, L.P. Boston, MA18.2MShares$154 Million2.59% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA15MShares$127 Million0.17% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$69.8 Million0.92% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$56.9 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.53MShares$55.2 Million0.41% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $734M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...